NTRK1 and cancer: Signaling pathways included in the term ‘pathways in cancer’ were analyzed for the availability of clinically applicable drugs using the database DGIdb [44], which identified several Receptor Tyrosine Kinases and the PI3K-AKT, Ras/MAPK, cell cycle and JAK-STAT pathway (Table 2).